Prot # CVT-301-004: A Phase 3, Randomized, Double-blind, Placebo-Controlled Study Investigating the Efficacy and Safety of CVT 301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/5/15 → 1/5/18

Funding

  • INC Research, LLC (CVT-301-004 // CVT-301-004)
  • Civitas Therapeutics, Inc. (CVT-301-004 // CVT-301-004)